Am J Transplant, Volume 19, Suppl 3 Archives - Page 128 of 214 - ATC Abstracts

2019 American Transplant Congress
Detection and Desensitization of Donor-Specific Antibody Reduces Risk of Early but Not Late Renal Transplant Failure in a Cohort of 1000 Cases
M. Tsai, C. Lee, C. Yang, C. Chen
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
*Purpose: The Human Organ Transplant Act in Taiwan was promulgated in 1987 and, thereafter, organ transplantation from brain-dead donors legalized. To review the results of…
2019 American Transplant Congress
Alemtuzumab versus Anti-Thymocyte Globulin Induction in the Setting of Immediate Post-Renal Transplant Acute Tubular Necrosis in an Urban, Minority Patient Population
K. Tejani, E. Benedetti, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: Post-renal transplant (RTx) delayed graft function (DGF) or slow graft function (SGF) increase the risk of rejection and impair allograft function. Lymphocyte depleting induction…
2019 American Transplant Congress
Panel Reactive Antibody Stratification as a Guide to Induction Selection in Deceased-Donor Kidney Transplantation: Impact of Clinical Practice on Outcomes
H. Ibrahim¹, J. Gregg¹, K. Alquadan¹, U. Akanit², K. L. Womer¹, A. H. Santos¹
¹Medicine, University of Florida, Gainesville, FL, ²Ubon Ratchathani University, Ubonratchathani, Thailand
*Purpose: We aimed to determine the outcomes associated with anti-thymocyte globulin (ATG), alemtuzumab (ALM) or interleukin-2 receptor antagonist (IL2-RA) induction in adult deceased-donor (DD) kidney…
2019 American Transplant Congress
Kidney Transplantation in Patients with Neurogenic Bladder
Z. Jurekovic, M. Knotek
Clinical Hospital Merkur, 10000 Zagreb, Croatia
*Purpose: Neurogenic bladder is a condition associated with high incidence of urinary tract infections (UTI). Infections in immunocompromised patients can be life-threatening and result in…
2019 American Transplant Congress
Kidney Volumes in Healthy Donors – Does Size Really Matter?
F. R. Schwartz¹, B. I. Shaw², F. Vernuccio¹, F. Rigiroli¹, F. Gonzalez¹, R. Lerebours³, K. Ravindra², D. Marin¹
¹Radiology, Duke University, Durham, NC, ²General Surgery, Duke University, Durham, NC, ³Biostatistics and Bioinformatics, Duke University, Durham, NC
*Purpose: To assess the relationship between craniocaudal renal diameters and renal volumes, as well as the frequency of appropriate renal selection for transplant using conventional…
2019 American Transplant Congress
Two-Year, Single Center, Retrospective Review of Herbal Supplement Use in Living Kidney Donors
N. Persun¹, D. Johnson¹, A. Leonberg-Yoo², J. Bahrainwala², P. P. Reese², D. M. Collins³, M. Houston³, A. Naji⁴, J. Trofe-Clark¹
¹Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA, ³Hospital of the University of Pennsylvania, Philadelphia, PA, ⁴Surgery, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA
*Purpose: Herbal supplement use in the evaluation phase of live kidney donors (LKD) poses challenges to providers. No formal management guidelines exist. Herbal supplements can…
2019 American Transplant Congress
Standardized Pain Management Post Donor Nephrectomy Results in Decreased Length of Stay
N. Alvey¹, B. Hohoff², M. Brokhof¹, N. Kenyon¹, E. Hollinger³
¹Pharmacy, Rush University Medical Center, Chicago, IL, ²Transplant, Rush University Medical Center, Chicago, IL, ³Surgery, Rush University Medical Center, Chicago, IL
*Purpose: Laparoscopic donor nephrectomy has reduced the burden associated with open surgery, but a significant percentage of donors still suffer from postoperative pain. It is…
2019 American Transplant Congress
Comparison Of Estimating Glomerular Filtration Equations In Living Kidney Donor Candidates Prior To Donation
S. Hebert¹, J. Xu², H. Ibrahim¹
¹Nephrology, Hypertension and Transplantation, Houston Methodist Hospital, Houston, TX, ²Houston Methodist Research Institute, Houston, TX
*Purpose: Serum creatinine-based estimated glomerular filtration rate (eGFR) models have been shown to over- or underestimate measured iohexol GFR (mGFR), but it is unclear if…
2019 American Transplant Congress
Transplant Provider Adherence to Cardiovascular Disease Primary Prevention Guidelines in Liver Transplant Recipients
M. Kosirog¹, P. T. Campbell¹, S. Montag², S. Connolly¹, A. Daud³, A. Das¹, S. Pine¹, D. Finn³, J. Levitsky¹, J. L. Holl⁴, D. M. Lloyd-Jones⁵, L. B. VanWagner⁶
¹Division of GI and Hepatology, Department of Medicine, Northwestern Medicine, Chicago, IL, ²Department of Preventative Medicine, Northwestern Medicine, Chicago, IL, ³Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁴Department of Pediatrics and Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁵Department of Preventive Medicine and Division of Cardiology, Department of Medicine, Northwestern Medicine, Chicago, IL, ⁶Division of GI and Hepatology, Department of Medicine and Department of Preventive Medicine, Northwestern Medicine, Chicago, IL
*Purpose: Blood pressure (BP) control, aspirin, and statin use are modifiable risk factors for primary prevention of atherosclerotic cardiovascular disease (ASCVD), stroke, and heart failure…
2019 American Transplant Congress
Proximal Splenic Artery Embolization Is A Safe And Effective Tool To Treat Two Sides Of The Same Coin After Liver Transplant: Persistent High Hepatic Artery Resistive Index And Refractory Ascites And Hydrothorax Due To Portal Hyperperfusion
L. Lomaglio, H. Matsushima, A. Simioni, G. D'Amico, T. Diago Uso, K. Hashimoto, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, C. Kwon, C. Coppa, M. Bayona Molano, C. Miller, C. Quintini
Cleveland Clinic, Cleveland, OH
*Purpose: Portal hyperperfusion(PHP) is a polymorphic and dangerous condition in liver transplant(LT) recipients.The aim of the present study was to assess the safety and the…